Determining Treatment for Older Patients with High-Risk MDS and AML: which Factors Predict Optimal Quality of Life?

Evidence is lacking to guide patients diagnosed with acute myeloid leukemia and high-risk myelodysplastic syndrome in selecting the best treatment for improving quality of life.

Source: Clinical Lymphoma, Myeloma and Leukemia - August 26, 2016 Category: Hematology Authors: Sara Tinsley, Brent Small, Susan McMillan, Rami Komrokji, Jeffrey Lancet Source Type: research